Clopamidum
Clopamid VP is a diuretic medicine from the group of thiazide-like diuretics. By increasing the excretion of water from the body, it reduces swelling.
The diuretic effect of the medicine occurs about 2 hours after oral administration, reaches its maximum after 1-4 hours, and lasts for about 24 hours from the time of administration.
Clopamid VP is used to treat swelling in heart, kidney, and liver failure.
Before starting treatment with Clopamid VP, discuss it with your doctor, pharmacist, or nurse:
Clopamid VP may cause water and electrolyte disorders. If you experience any of the following symptoms while taking Clopamid VP: muscle cramps, weakness, drowsiness, low blood pressure, rapid heartbeat, thirst, gastrointestinal symptoms, inform your doctor. These may be symptoms of water and electrolyte disorders.
While taking Clopamid VP, avoid a strict low-sodium diet. In the case of long-term therapy, it is recommended to consume potassium-rich foods (dried fruits, legumes, fruits, fish, low-fat cheeses).
Tell your doctor or pharmacist about all medicines you are taking or have recently taken, as well as any medicines you plan to take.
Particularly inform your doctor or pharmacist if you are taking:
Clopamid VP can be taken with or without food.
Avoid excessive alcohol consumption while taking Clopamid VP.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, consult your doctor or pharmacist before taking this medicine.
Clopamid VP is contraindicated during pregnancy and breastfeeding.
Do not drive vehicles or operate machinery during the initial period of taking Clopamid VP, as it may cause dizziness or excessive fatigue.
Always take this medicine exactly as your doctor has told you. If you are unsure, consult your doctor or pharmacist.
Recommended dose:
Adults:
The initial dose, depending on the severity of symptoms, is 20-40 mg per day, preferably in the morning, after a meal. If necessary, your doctor will increase the daily dose to 60 mg and gradually decrease it as the swelling subsides. The maintenance dose is 10-20 mg per day or every other day.
Elderly patients (over 65 years):
No dose adjustment is necessary.
Patients with liver and kidney function disorders:
The medicine should not be used in patients with severe kidney or liver failure.
Children and adolescents:
Due to the lack of appropriate studies, the use of this medicine is not recommended in this age group.
Take Clopamid VP regularly.
If you take more than the recommended dose of Clopamid VP, you may experience:
decreased blood pressure when changing position from sitting or lying down to standing or sitting up, dizziness, fainting, nausea, vomiting, dizziness, water and electrolyte disturbances (mainly hypokalemia).
In case of overdose, consult your doctor, who will provide appropriate treatment.
If you miss a dose, take it as soon as possible. If it is almost time for your next dose, skip the missed dose. Take the next dose at the usual time. Do not take a double dose to make up for the missed dose.
Stopping treatment with Clopamid VP may worsen the condition for which it was prescribed (worsening of swelling). Therefore, treatment should only be stopped under medical supervision.
If you have any further doubts about taking this medicine, consult your doctor or pharmacist.
Like all medicines, Clopamid VP can cause side effects, although not everybody gets them.
Generally, in connection with the use of thiazide diuretics, changes in blood counts, including decreased platelet count and white blood cell count, allergic reactions (including pneumonitis, pulmonary edema, severe skin reactions), orthostatic hypotension, pancreatitis, intrahepatic cholestasis, allergic skin reactions, urticaria, increased sensitivity to sunlight, sexual function disorders, impotence, may be reported.
If you experience any side effects, including those not listed in this leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl. Side effects can also be reported to the marketing authorization holder. By reporting side effects, you can help provide more information on the safety of this medicine.
Store in the original packaging.
Keep the medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer need. This will help protect the environment.
Clopamid VP tablets are packaged in blisters of 20 tablets each, made of Al/PVC foil.
A single carton contains 1 blister with an information leaflet.
Bausch Health Ireland Limited
3013 Lake Drive
Citywest Business Campus
Dublin 24, D24PPT3
Ireland
ICN Polfa Rzeszów S.A.
ul. Przemysłowa 2
35-105 Rzeszów, Poland
Tel. (48 17) 865 51 00
Date of leaflet approval:May 2025
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.